Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.

Breedt J, Teras J, Gardovskis J, Maritz FJ, Vaasna T, Ross DP, Gioud-Paquet M, Dartois N, Ellis-Grosse EJ, Loh E; Tigecycline 305 cSSSI Study Group.

Antimicrob Agents Chemother. 2005 Nov;49(11):4658-66.

2.

Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus.

Campistol JM, Holt DW, Epstein S, Gioud-Paquet M, Rutault K, Burke JT; Sirolimus European Renal Transplant Study Group*.

Transpl Int. 2005 Sep;18(9):1028-35.

3.

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF; Rapamune Maintenance Regimen Trial.

J Am Soc Nephrol. 2004 Mar;15(3):809-17.

4.

Pharmacokinetics of pirprofen in children with juvenile chronic arthritis.

Hallé F, Marfil F, Sioufi A, Dubois JP, Gioud-Paquet M, Lenoir G, Prieur AM.

Eur J Drug Metab Pharmacokinet. 1991 Jan-Mar;16(1):29-34.

PMID:
1936058
5.

Antiestrogen antibodies, oral contraception and systemic lupus erythematosus.

Beaumont V, Gioud-Paquet M, Kahn MF, Beaumont JL.

Clin Physiol Biochem. 1989;7(5):263-8.

PMID:
2805575
6.

[Symptomatic and prognostic differences according to ethnic group in systemic lupus erythematosus. A controlled study of 3 populations].

Gioud-Paquet M, Chamot AM, Bourgeois P, Meyer O, Kahn MF.

Presse Med. 1988 Jan 30;17(3):103-6. French.

PMID:
2964593
7.

IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.

Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC.

Ann Rheum Dis. 1987 Jan;46(1):65-71.

8.

In vitro production of antihistone antibodies in systemic lupus erythematosus (SLE)

Gioud-Paquet M, Martinon S, Bouvier M, Lejeune E, Monier JC.

Thymus. 1987;9(2):127-9. No abstract available.

PMID:
3590273
9.

[Absence of anti-LAV antibodies in connective tissue diseases].

Gioud Paquet M, Kahn MF, Rouzioux C, Brun-Vezinet F, Rey MA.

Presse Med. 1986 Apr 26;15(17):802. French. No abstract available.

PMID:
3012506
10.

LAV/HTLV-III antibodies in connective tissue diseases.

Gioud-Paquet M, Kahn MF, Rouzioux C, Brun-Vezinet F, Rey MA.

Lancet. 1985 Sep 7;2(8454):554. No abstract available.

PMID:
2863569

Supplemental Content

Loading ...
Support Center